Metric Snapshot
- Latest value
- $109,658,000
- Coverage range
- 31 Dec 2019 - 31 Dec 2025
- Fact rows
- 25
Financial Metric Page
ARROWHEAD PHARMACEUTICALS, INC.: Operating Lease, Liability
Latest period: Q4 2025. Period end: 31 Dec 2025. Units: USD. Frequency: quarterly.
Present value of lessee's discounted obligation for lease payments from operating lease.
What This Metric Tells You
- Shows the reported level of operating lease, liability over 31 Dec 2019 - 31 Dec 2025.
- Includes year-over-year change points to highlight acceleration or slowdown.
- Built from 25 SEC fact rows for this metric and issuer.
How To Read This Chart
- Start with the latest point, then compare it with the prior periods to see direction.
- Use quarterly sequence to compare like-for-like periods.
- Use YoY change bars to separate growth from contraction across matching periods.
Official SEC Source
Source: SEC Company Facts
Based on 10-Q / 10-K XBRL facts.
Metric Details
- Metric
- Operating Lease, Liability (OperatingLeaseLiability)
- Taxonomy
- us-gaap
- Units tracked
- USD
- Frequency coverage
- quarterly
- History range
- 31 Dec 2019 - 31 Dec 2025
- Facts on this page
- 25
- Description
- Present value of lessee's discounted obligation for lease payments from operating lease.
- Metric-level SEC endpoint
- Open SEC company concept
Chart Context
Compare periods with the same frequency first, then use YoY and TTM series to confirm whether changes are structural or one-off.
Operating Lease, Liability, Quarterly (USD)
Operating Lease, Liability, YoY Quarterly Change (%)
ARROWHEAD PHARMACEUTICALS, INC. Quarterly Operating Lease, Liability (USD)
| Period | Value | YoY Chg | Change % | Date | Report | Filed | Fiscal Year | Fiscal Period |
|---|---|---|---|---|---|---|---|---|
| Q4 2025 | $109,658,000 | -$6,198,000 | -5.4% | 31 Dec 2025 | 10-Q | 05 Feb 2026 | 2026 | Q1 |
| Q3 2025 | $111,401,000 | -$5,968,000 | -5.1% | 30 Sep 2025 | 10-K | 25 Nov 2025 | 2025 | FY |
| Q2 2025 | $112,700,000 | -$5,393,000 | -4.6% | 30 Jun 2025 | 10-Q | 07 Aug 2025 | 2025 | Q3 |
| Q1 2025 | $114,311,000 | -$4,606,000 | -3.9% | 31 Mar 2025 | 10-Q | 12 May 2025 | 2025 | Q2 |
| Q4 2024 | $115,856,000 | -$2,722,000 | -2.3% | 31 Dec 2024 | 10-Q | 10 Feb 2025 | 2025 | Q1 |
| Q3 2024 | $117,369,000 | +$2,198,000 | +1.9% | 30 Sep 2024 | 10-K | 26 Nov 2024 | 2024 | FY |
| Q2 2024 | $118,093,000 | +$35,359,000 | +43% | 30 Jun 2024 | 10-Q | 08 Aug 2024 | 2024 | Q3 |
| Q1 2024 | $118,917,000 | +$36,136,000 | +44% | 31 Mar 2024 | 10-Q | 09 May 2024 | 2024 | Q2 |
| Q4 2023 | $118,578,000 | +$36,444,000 | +44% | 31 Dec 2023 | 10-Q | 06 Feb 2024 | 2024 | Q1 |
| Q3 2023 | $115,171,000 | +$33,595,000 | +41% | 30 Sep 2023 | 10-K | 29 Nov 2023 | 2023 | FY |
| Q2 2023 | $82,734,000 | +$1,620,000 | +2% | 30 Jun 2023 | 10-Q | 07 Aug 2023 | 2023 | Q3 |
| Q1 2023 | $82,781,000 | +$57,173,000 | +223% | 31 Mar 2023 | 10-Q | 02 May 2023 | 2023 | Q2 |
| Q4 2022 | $82,134,000 | +$56,819,000 | +224% | 31 Dec 2022 | 10-Q | 06 Feb 2023 | 2023 | Q1 |
| Q3 2022 | $81,576,000 | +$56,031,000 | +219% | 30 Sep 2022 | 10-K | 28 Nov 2022 | 2022 | FY |
| Q2 2022 | $81,114,000 | +$56,970,000 | +236% | 30 Jun 2022 | 10-Q | 04 Aug 2022 | 2022 | Q3 |
| Q1 2022 | $25,608,000 | +$1,808,000 | +7.6% | 31 Mar 2022 | 10-Q | 10 May 2022 | 2022 | Q2 |
| Q4 2021 | $25,315,000 | +$4,447,000 | +21% | 31 Dec 2021 | 10-Q | 02 Feb 2022 | 2022 | Q1 |
| Q3 2021 | $25,545,000 | +$4,407,045 | +21% | 30 Sep 2021 | 10-K | 22 Nov 2021 | 2021 | FY |
| Q2 2021 | $24,144,000 | +$2,772,323 | +13% | 30 Jun 2021 | 10-Q | 05 Aug 2021 | 2021 | Q3 |
| Q1 2021 | $23,800,000 | +$8,932,811 | +60% | 31 Mar 2021 | 10-Q | 04 May 2021 | 2021 | Q2 |
| Q4 2020 | $20,868,000 | +$6,029,099 | +41% | 31 Dec 2020 | 10-Q | 04 Feb 2021 | 2021 | Q1 |
| Q3 2020 | $21,137,955 | 30 Sep 2020 | 10-K | 23 Nov 2020 | 2020 | FY | ||
| Q2 2020 | $21,371,677 | 30 Jun 2020 | 10-Q | 05 Aug 2020 | 2020 | Q3 | ||
| Q1 2020 | $14,867,189 | 31 Mar 2020 | 10-Q | 07 May 2020 | 2020 | Q2 | ||
| Q4 2019 | $14,838,901 | 31 Dec 2019 | 10-Q | 05 Feb 2020 | 2020 | Q1 |
* An asterisk sign (*) next to the value indicates that the value is likely invalid.